Targeting HIV/HCV Coinfection Using a Machine Learning-Based Multiple Quantitative Structure-Activity Relationships (Multiple QSAR) Method

Targeting HIV/HCV Coinfection Using a Machine Learning-Based Multiple Quantitative Structure-Activity Relationships (Multiple QSAR) Method

Human immunodeficiency virus type-1 and hepatitis C virus (HIV/HCV) coinfection occurs when a patient is simultaneously infected with both human immunodeficiency virus type-1 (HIV-1) and hepatitis C virus (HCV), which is common today in certain populations. However, the treatment of coinfection is a...

Full description

Bibliographic Details
Main Authors:	Yu Wei, Wei Li, Tengfei Du, Zhangyong Hong, Jianping Lin
Format:	Article
Language:	English
Published:	MDPI AG 2019-07-01
Series:	International Journal of Molecular Sciences
Subjects:	HIV/HCV coinfection machine learning multiple QSAR method multitarget inhibitors polypharmacology drug discovery
Online Access:	https://www.mdpi.com/1422-0067/20/14/3572

Similar Items

HIV AND HCV COINFECTION: PREVALENCE, ASSOCIATED FACTORS AND GENOTYPE CHARACTERIZATION IN THE MIDWEST REGION OF BRAZIL
by: Solange Zacalusni Freitas, et al.
Published: (2014-12-01)

A Definition of “Multitargeticity”: Identifying Potential Multitarget and Selective Ligands Through a Vector Analysis
by: Juan Francisco Sánchez-Tejeda, et al.
Published: (2020-03-01)

Efficacy Of Pegylated Interferon And Ribavirin Treatment In Coinfected HIV HCV Patients
by: Dumitru Irina Magdalena, et al.
Published: (2017-02-01)

Liver Fibrosis in HCV Monoinfected and HIV/HCV Coinfected Patients: Dysregulation of Matrix Metalloproteinases (MMPs) and Their Tissue Inhibitors TIMPs and Effect of HCV Protease Inhibitors
by: Tiziana Latronico, et al.
Published: (2016-03-01)

HIV/HCV coinfection model: a fractional-order perspective for the effect of the HIV viral load
by: Ana RM Carvalho, et al.
Published: (2018-01-01)

Computational polypharmacology comes of age
by: Giulio eRastelli, et al.
Published: (2015-07-01)

Effects of Pegylated Interferon Alpha and Ribavirin (pegIFN-α/RBV) Therapeutic Approach on Regulatory T Cells in HCV-Monoinfected and HCV/HIV-Coinfected Patients
by: Kamil Grubczak, et al.
Published: (2021-07-01)

Budget impact analysis of sofosbuvir-based regimens for the treatment of HIV/HCV-coinfected patients in northern Italy: a multicenter regional simulation
by: Cenderello G, et al.
Published: (2015-12-01)

Consistency of spatial dynamics of HIV-1 and HCV among HIV-1/HCV coinfected drug users in China
by: Yu Wang, et al.
Published: (2021-09-01)

Polypharmacology of dopamine D1-like receptor antagonists
by: Nikolić Katarina, et al.
Published: (2015-01-01)

Sustained virological response according to the type of early virological response in HCV and HCV/HIV
by: Paulo R. Lerias de Almeida, et al.
Published: (2010-04-01)

HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients
by: Óscar Brochado, et al.
Published: (2021-03-01)

Impact of HCV Eradication on Lipid Metabolism in HIV/HCV Coinfected Patients: Data from ICONA and HepaICONA Foundation Cohort Study
by: Martina Spaziante, et al.
Published: (2021-07-01)

The influence of HCV coinfection on clinical, immunological and virological responses to HAART in HIV-patients
by: Ricardo A. Carmo, et al.

Response predictors and clinical benefits of hepatitis C retreatment with pegylated interferon and ribavirin in HIV/HCV coinfection
by: Mario Peribañez-Gonzalez, et al.
Published: (2013-03-01)

Liver Stiffness Hinders Normalization of Systemic Inflammation and Endothelial Activation after Hepatitis C Virus (HCV) Eradication in HIV/HCV Coinfected Patients
by: Beatriz Álvarez, et al.
Published: (2020-06-01)

Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination
by: Victor Virlogeux, et al.
Published: (2017-12-01)

HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients
by: Óscar Brochado-Kith, et al.
Published: (2021-08-01)

QSAR-Co-X: an open source toolkit for multitarget QSAR modelling
by: Amit Kumar Halder, et al.
Published: (2021-04-01)

Evaluation of the therapeutic response of hepatitis C in coinfected patients (HIV/HCV): a study of cases from a hospital for chronic liver diseases in the Eastern Brazilian Amazon
by: Ivanete do Socorro Abraçado Amaral, et al.
Published: (2013-01-01)

Exploring EZH2-Proteasome Dual-Targeting Drug Discovery through a Computational Strategy to Fight Multiple Myeloma
by: Filipe G. A. Estrada, et al.
Published: (2021-09-01)

Multitargeting Compounds: A Promising Strategy to Overcome Multi-Drug Resistant Tuberculosis
by: Giovanni Stelitano, et al.
Published: (2020-03-01)

Clinical Relevance of Torque Teno Virus (TTV) in HIV/HCV Coinfected and HCV Monoinfected Patients Treated with Direct-Acting Antiviral Therapy
by: Daniele Lapa, et al.
Published: (2021-05-01)

Identification of the transcripts associated with spontaneous HCV clearance in individuals co-infected with HIV and HCV
by: Yue Chen, et al.
Published: (2016-11-01)

Detection of HIV and HCV RNA in semen from Brazilian coinfected men using multiplex PCR before and after semen washing Detecção do RNA do HIV e HCV em sêmen de homens brasileiros, usando PCR multiplex antes e depois do "semen washing"
by: Cynthia Liliane Motta do Canto, et al.
Published: (2006-08-01)

Synthesis, Docking, 3-D-Qsar, and Biological Assays of Novel Indole Derivatives Targeting Serotonin Transporter, Dopamine D2 Receptor, and Mao-A Enzyme: In the Pursuit for Potential Multitarget Directed Ligands
by: Christopher Cerda-Cavieres, et al.
Published: (2020-10-01)

Multiscale Virtual Screening Optimization for Shotgun Drug Repurposing Using the CANDO Platform
by: Matthew L. Hudson, et al.
Published: (2021-04-01)

Difference of Intrahost Dynamics of the Second Human Pegivirus and Hepatitis C Virus in HPgV-2/HCV-Coinfected Patients
by: Yuanhao Liang, et al.
Published: (2021-08-01)

Barriers to treatment of hepatitis C in HIV/HCV coinfected adults in Brazil
by: Maria Cássia Mendes-Corrêa, et al.

Modeling the effect of HIV coinfection on clearance and sustained virologic response during treatment for hepatitis C virus
by: Ruthie Birger, et al.
Published: (2015-09-01)

Characteristics of co-infections by HCV and HBV among Brazilian patients infected by HIV-1 and/or HTLV-1
by: Marcia Moreira, et al.

QSAR models for prediction study of HIV protease inhibitors using support vector machines, neural networks and multiple linear regression
by: Rachid Darnag, et al.
Published: (2017-02-01)

Clinical laboratory assessment of hepatitis C and HIV coinfected patients according to the antiretroviral therapy received Avaliação clínico-laboratorial de pacientes co-infectados com o vírus da hepatite C e HIV-1 em relação ao tipo de terapia antirretroviral recebida
by: Roberto M. Carrasco Navarro, et al.
Published: (2005-02-01)

HIV/HCV-coinfection: which role can new antiretrovirals such as integrase inhibitors play?
by: Vogel Martin, et al.
Published: (2009-11-01)

SKI-178: A multitargeted inhibitor of sphingosine kinase and microtubule dynamics demonstrating therapeutic efficacy in acute myeloid leukemia models
by: Jeremy A Hengst, et al.
Published: (2017-01-01)

Epidemiology of HIV/HCV coinfection in patients cared for at the Tropical Medicine Foundation of Amazonas
by: Marilú Barbieri Victoria, et al.

Fast relapse and high drop out rate of 48 weeks daily interferon monotherapy in HIV-infected patients with chronic hepatitis C
by: Patruno Savino FA, et al.
Published: (2002-08-01)

MTLD, a Database of Multiple Target Ligands, the Updated Version
by: Chao Chen, et al.
Published: (2017-09-01)

Causes of T lymphocyte activation in HIV-infected patients coinfected with hepatitis C virus
by: K V Shmagel, et al.
Published: (2016-11-01)

Biochemical non-invasive assessment of liver fibrosis cannot replace biopsy in HIV-HCV coinfected patients
by: Dimas A. Kliemann, et al.
Published: (2016-01-01)

Cannot write session to /tmp/vufind_sessions/sess_hl74ejsfom33uvvd1dur88b4s8